SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-21-236933
Filing Date
2021-08-05
Accepted
2021-08-05 06:51:15
Documents
48
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d181533d10q.htm   iXBRL 10-Q 850841
2 EX-31.1 d181533dex311.htm EX-31.1 10668
3 EX-31.2 d181533dex312.htm EX-31.2 10825
4 EX-32.1 d181533dex321.htm EX-32.1 5851
  Complete submission text file 0001193125-21-236933.txt   3445020

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA mdgl-20210630.xsd EX-101.SCH 25052
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mdgl-20210630_cal.xml EX-101.CAL 25072
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mdgl-20210630_def.xml EX-101.DEF 84627
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE mdgl-20210630_lab.xml EX-101.LAB 226305
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mdgl-20210630_pre.xml EX-101.PRE 171206
10 EXTRACTED XBRL INSTANCE DOCUMENT d181533d10q_htm.xml XML 527791
Mailing Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 404-380-9263
MADRIGAL PHARMACEUTICALS, INC. (Filer) CIK: 0001157601 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33277 | Film No.: 211146192
SIC: 2834 Pharmaceutical Preparations